![Alexander Hardy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Hardy
Algemeen Directeur bij
BIOMARIN PHARMACEUTICAL INC.
Vermogen: 3 M $ op 30-06-2026
Profiel
Alexander Hardy is currently President, Chief Executive Officer & Director at BioMarin Pharmaceutical, Inc. since 2023.
Mr. Hardy is also a Director at Pharmaceutical Research & Manufacturers of America and a Member of The Wall Street Journal CEO Council.
Formerly, Mr. Hardy was Chief Executive Officer & Director at Genentech, Inc. Mr. Hardy completed undergraduate studies at the University of Cambridge and earned an MBA from the Stephen M.
Ross School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-04-2026 | 52.422 ( 0,03% ) | 3 M $ | 30-06-2026 |
Actieve functies van Alexander Hardy
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Algemeen Directeur | 01-12-2023 |
The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Bestuurslid | - |
Eerdere bekende functies van Alexander Hardy
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Algemeen Directeur | - |
Opleiding van Alexander Hardy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wall Street Journal CEO Council |
Kies MarketScreener 
